Advanced search
1 file | 75.58 KB Add to list

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

(2016) JOURNAL OF MEDICAL VIROLOGY. 88(1). p.94-99
Author
Organization
Keywords
persons who inject drugs, hepatitis C, HEPATITIS-C VIRUS, PEOPLE, COHORT, direct acting antivirals, telaprevir, boceprevir, CHRONIC HCV INFECTION, GLOBAL EPIDEMIOLOGY, USERS, PEGINTERFERON, RIBAVIRIN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 75.58 KB

Citation

Please use this url to cite or link to this publication:

MLA
Arain, A et al. “Belgian Experience with Triple Therapy with Boceprevir and Telaprevir in Genotype 1 Infected Patients Who Inject Drugs.” JOURNAL OF MEDICAL VIROLOGY 88.1 (2016): 94–99. Print.
APA
Arain, A., Bourgeois, S., de Galocsy, C., Henrion, J., Deltenre, P., d’ Heygere, F., George, C., et al. (2016). Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. JOURNAL OF MEDICAL VIROLOGY, 88(1), 94–99.
Chicago author-date
Arain, A, S Bourgeois, C de Galocsy, J Henrion, P Deltenre, F d’ Heygere, C George, et al. 2016. “Belgian Experience with Triple Therapy with Boceprevir and Telaprevir in Genotype 1 Infected Patients Who Inject Drugs.” Journal of Medical Virology 88 (1): 94–99.
Chicago author-date (all authors)
Arain, A, S Bourgeois, C de Galocsy, J Henrion, P Deltenre, F d’ Heygere, C George, B Bastens, L Van Overbeke, R Verrando, L Bruckers, C Mathei, F Buntinx, Hans Van Vlierberghe, S Francque, W Laleman, C Moreno, F Janssens, F Nevens, and G Robaeys. 2016. “Belgian Experience with Triple Therapy with Boceprevir and Telaprevir in Genotype 1 Infected Patients Who Inject Drugs.” Journal of Medical Virology 88 (1): 94–99.
Vancouver
1.
Arain A, Bourgeois S, de Galocsy C, Henrion J, Deltenre P, d’ Heygere F, et al. Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. JOURNAL OF MEDICAL VIROLOGY. 2016;88(1):94–9.
IEEE
[1]
A. Arain et al., “Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs,” JOURNAL OF MEDICAL VIROLOGY, vol. 88, no. 1, pp. 94–99, 2016.
@article{6993687,
  author       = {Arain, A and Bourgeois, S and de Galocsy, C and Henrion, J and Deltenre, P and d'Heygere, F and George, C and Bastens, B and Van Overbeke, L and Verrando, R and Bruckers, L and Mathei, C and Buntinx, F and Van Vlierberghe, Hans and Francque, S and Laleman, W and Moreno, C and Janssens, F and Nevens, F and Robaeys, G},
  issn         = {0146-6615},
  journal      = {JOURNAL OF MEDICAL VIROLOGY},
  keywords     = {persons who inject drugs,hepatitis C,HEPATITIS-C VIRUS,PEOPLE,COHORT,direct acting antivirals,telaprevir,boceprevir,CHRONIC HCV INFECTION,GLOBAL EPIDEMIOLOGY,USERS,PEGINTERFERON,RIBAVIRIN},
  language     = {eng},
  number       = {1},
  pages        = {94--99},
  title        = {Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs},
  url          = {http://dx.doi.org/10.1002/jmv.24308},
  volume       = {88},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: